ATE331037T1 - Isoliertes frpb nukleinsäuremolekül und entsprechende impfstoff - Google Patents

Isoliertes frpb nukleinsäuremolekül und entsprechende impfstoff

Info

Publication number
ATE331037T1
ATE331037T1 AT96912605T AT96912605T ATE331037T1 AT E331037 T1 ATE331037 T1 AT E331037T1 AT 96912605 T AT96912605 T AT 96912605T AT 96912605 T AT96912605 T AT 96912605T AT E331037 T1 ATE331037 T1 AT E331037T1
Authority
AT
Austria
Prior art keywords
nucleic acid
frpb
acid molecule
isolated
corresponding vaccine
Prior art date
Application number
AT96912605T
Other languages
English (en)
Inventor
P Fredrick Sparling
Margaret Beucher
Original Assignee
Univ North Carolina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ North Carolina filed Critical Univ North Carolina
Application granted granted Critical
Publication of ATE331037T1 publication Critical patent/ATE331037T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT96912605T 1995-04-07 1996-04-08 Isoliertes frpb nukleinsäuremolekül und entsprechende impfstoff ATE331037T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41896495A 1995-04-07 1995-04-07

Publications (1)

Publication Number Publication Date
ATE331037T1 true ATE331037T1 (de) 2006-07-15

Family

ID=23660253

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96912605T ATE331037T1 (de) 1995-04-07 1996-04-08 Isoliertes frpb nukleinsäuremolekül und entsprechende impfstoff

Country Status (8)

Country Link
US (3) US6265567B1 (de)
EP (1) EP0830456B1 (de)
JP (1) JP3797490B2 (de)
AT (1) ATE331037T1 (de)
AU (1) AU5537096A (de)
CA (1) CA2217522C (de)
DE (1) DE69636285D1 (de)
WO (1) WO1996031618A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6265567B1 (en) * 1995-04-07 2001-07-24 University Of North Carolina At Chapel Hill Isolated FrpB nucleic acid molecule
EP1900818A3 (de) * 1997-11-06 2008-06-11 Novartis Vaccines and Diagnostics S.r.l. Neissersche Antigene
US6914131B1 (en) 1998-10-09 2005-07-05 Chiron S.R.L. Neisserial antigens
RU2347813C2 (ru) * 1997-11-06 2009-02-27 Чирон С.П.А. Антигены нейссерий
GB9808866D0 (en) * 1998-04-24 1998-06-24 Smithkline Beecham Biolog Novel compounds
BR9910005A (pt) * 1998-04-29 2001-01-16 American Cyanamid Co Composição de vacina, processos para imunização contra neisseria gonorrhoeae e para preparar uma composição de vacina, sequência de dna isolada e purificada, plasmìdeo, célula hospedeira, processo para produção de uma proteìna pilina recombinante quimérica de neisseria gonorrhoeae e neisseria meningitidis, proteìna pilina recombinante quimérica isolada e purificada de neisseria gonorhoeae e neisseria meningitidis, e, processo para imunização contra neisseria muningitidis
EP2261347A3 (de) * 1998-05-01 2012-01-11 Novartis Vaccines and Diagnostics, Inc. Antigene und Zusammensetzungen gegen Neisseria meningitidis
GB9810276D0 (en) * 1998-05-13 1998-07-15 Smithkline Beecham Biolog Novel compounds
US6692752B1 (en) 1999-09-08 2004-02-17 Smithkline Beecham Biologicals S.A. Methods of treating human females susceptible to HSV infection
AU2107400A (en) * 1999-01-15 2000-08-01 Smithkline Beecham Biologicals (Sa) Neisseria meningitidis antigen
GB9918319D0 (en) 1999-08-03 1999-10-06 Smithkline Beecham Biolog Vaccine composition
EP1226253A2 (de) * 1999-10-29 2002-07-31 Chiron S.P.A. Antigene peptide aus neisseria
DK1947187T5 (da) 2000-02-28 2011-10-24 Novartis Vaccines & Diagnostic Hybrid ekspression af neisserial-proteiner
GB0103171D0 (en) 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition
CA2493124C (en) 2002-08-02 2014-04-29 Glaxosmithkline Biologicals S.A. Vaccine
GB0220199D0 (en) * 2002-08-30 2002-10-09 Univ Utrecht Mutant protein and refolding method
MXPA05004528A (es) 2002-11-01 2005-07-26 Glaxosmithkline Biolog Sa Composicion inmunogenica.
GB2414667A (en) * 2004-06-03 2005-12-07 Isis Innovation Vaccine compositions of N. meningitidis PorA and FetA antigens
GB0505996D0 (en) 2005-03-23 2005-04-27 Glaxosmithkline Biolog Sa Fermentation process
DE602007003596D1 (de) 2006-06-12 2010-01-14 Glaxosmithkline Biolog Sa Impfstoff

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6265567B1 (en) * 1995-04-07 2001-07-24 University Of North Carolina At Chapel Hill Isolated FrpB nucleic acid molecule

Also Published As

Publication number Publication date
EP0830456B1 (de) 2006-06-21
US20030096368A1 (en) 2003-05-22
CA2217522C (en) 2011-09-20
JP3797490B2 (ja) 2006-07-19
EP0830456A4 (de) 2001-03-14
US6265567B1 (en) 2001-07-24
EP0830456A1 (de) 1998-03-25
US20050271681A1 (en) 2005-12-08
DE69636285D1 (de) 2006-08-03
CA2217522A1 (en) 1996-10-10
AU5537096A (en) 1996-10-23
WO1996031618A1 (en) 1996-10-10
JPH11503322A (ja) 1999-03-26

Similar Documents

Publication Publication Date Title
DE69636285D1 (de) ISOLIERTES FrpB NUKLEINSÄUREMOLEKÜL UND ENTSPRECHENDE IMPFSTOFF
DK0758248T3 (da) Formuleringer til faktor IX
BR9707819A (pt) Imunogenos peptidicos
DE69729786D1 (de) Hochkonzentrierte, lyophilisierte und flüssige faktor-ix formulierungen
DE69620877D1 (de) Arzneimittelformulierungen für il-12
ATE196913T1 (de) Neuartige peptidderivate
DK0951473T3 (da) Cyclosporinderivat, fremstilling af dette og farmaceutiske præparater indeholdende dette
DK1200418T3 (da) Nematodicide trifluorbutener
TR200101867T2 (tr) CCR5 modülatörleri olarak piperidinler
NO971889L (no) Forbindelser og sammensetninger for levering av aktive midler
CY1106366T1 (el) Ενωση λακταμης για την αναστολη της απελευθερωσης ή της συνθεσης βητα-αμυλοειδους πεπτιδιου
TR200806259T2 (tr) Tüberkülozun teşhisi ve immünoterapi yolu ile önlenmesine mahsus yöntemler ve bileşikler
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
RU95106362A (ru) Производные липопептида, способ их получения, содержащая их фармацевтическая композиция и способ ее получения
ATE210988T1 (de) Zytotoxischer aminozucker und verwandte zuckerderivate von indolopyrrolocarbazolen
DK0705100T3 (da) Terapeutiske substituerede guanidiner
DE69331739D1 (de) Neuartige pharmazeutische verwendungen von krill-enzymen
PT789590E (pt) Imunopotenciacao induzida por quitosano
EP0932613A4 (de) Expressionsblockierung von virulenten faktoren in s. aureus
CY1105235T1 (el) Συνθεσεις λασοφοξιφενης
AU6415994A (en) Substituted caprolactams and derivatives thereof useful for treatment of hiv disease
DE69330268D1 (de) Hämoregulierende peptide
AU5163598A (en) Novel hepatitis b inhibitors
BR9710992A (pt) Derivados anticovulsivos úteis no tratamento de psorìase
DE69619123D1 (de) Hämoregulatorische verbindungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties